Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors.

Naggie S, Miller BA, Zuzak KB, Pence BW, Mayo AJ, Nicholson BP, Kutty PK, McDonald LC, Woods CW.

Am J Med. 2011 Mar;124(3):276.e1-7. doi: 10.1016/j.amjmed.2010.10.013.

PMID:
21396512
2.
3.

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.

Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, Pencina M, Talmor D.

Arch Intern Med. 2010 May 10;170(9):784-90. doi: 10.1001/archinternmed.2010.89.

PMID:
20458086
4.

Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.

McFarland LV, Clarridge JE, Beneda HW, Raugi GJ.

Clin Infect Dis. 2007 Nov 1;45(9):1141-51. Epub 2007 Sep 26.

PMID:
17918075
5.

A case-control study of community-associated Clostridium difficile infection.

Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN.

J Antimicrob Chemother. 2008 Aug;62(2):388-96. doi: 10.1093/jac/dkn163. Epub 2008 Apr 22.

PMID:
18434341
6.

Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea.

Bauer MP, Goorhuis A, Koster T, Numan-Ruberg SC, Hagen EC, Debast SB, Kuijper EJ, van Dissel JT.

Neth J Med. 2008 May;66(5):207-11. Review.

7.

Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study.

Leonard AD, Ho KM, Flexman J.

Intern Med J. 2012 May;42(5):591-4. doi: 10.1111/j.1445-5994.2012.02770.x.

PMID:
22616966
8.

Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.

Stevens V, Dumyati G, Brown J, Wijngaarden E.

Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1035-42. doi: 10.1002/pds.2198. Epub 2011 Aug 10.

PMID:
21833992
9.

Impact of Clostridium difficile on inflammatory bowel disease.

Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S, Skaros S, Weber LR, Komorowski RA, Knox JF, Emmons J, Bajaj JS, Binion DG.

Clin Gastroenterol Hepatol. 2007 Mar;5(3):345-51.

PMID:
17368234
10.

Clostridium difficile infection: managing the risks.

DeDea L.

JAAPA. 2012 May;25(5):16. No abstract available.

PMID:
22712142
11.

Proton pump inhibitors are an independent risk factor for an increased length of hospital stay in patients with Clostridium difficile infection.

Nachnani JS, Bulchandani D, Allen MJ.

Indian J Gastroenterol. 2008 Jul-Aug;27(4):171-2. No abstract available.

PMID:
18974472
12.

Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding.

Bliss DZ, Johnson S, Savik K, Clabots CR, Willard K, Gerding DN.

Ann Intern Med. 1998 Dec 15;129(12):1012-9.

PMID:
9867755
13.

Investigation of critical care unit utilization and mortality in patients infected with Clostridium difficile.

Gasperino J, Garala M, Cohen HW, Kvetan V, Currie B.

J Crit Care. 2010 Jun;25(2):282-6. doi: 10.1016/j.jcrc.2009.04.002. Epub 2009 Jul 9.

PMID:
19592210
14.

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Dial S, Delaney JA, Barkun AN, Suissa S.

JAMA. 2005 Dec 21;294(23):2989-95.

PMID:
16414946
15.

Clostridium difficile infection and proton pump inhibitors.

Pohl JF.

Curr Opin Pediatr. 2012 Oct;24(5):627-31. doi: 10.1097/MOP.0b013e328355a3e1. Review.

PMID:
22781139
16.

Clostridium difficile infection in humans and animals, differences and similarities.

Keessen EC, Gaastra W, Lipman LJ.

Vet Microbiol. 2011 Dec 15;153(3-4):205-17. doi: 10.1016/j.vetmic.2011.03.020. Epub 2011 Mar 26. Review.

PMID:
21530110
17.

Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors.

Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ.

Clin Infect Dis. 2007 Dec 15;45(12):1543-9. doi: 10.1086/523582.

PMID:
18190314
18.

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection.

Dial S, Kezouh A, Dascal A, Barkun A, Suissa S.

CMAJ. 2008 Oct 7;179(8):767-72. doi: 10.1503/cmaj.071812.

19.

Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study.

Barbut F, Corthier G, Charpak Y, Cerf M, Monteil H, Fosse T, Trévoux A, De Barbeyrac B, Boussougant Y, Tigaud S, Tytgat F, Sédallian A, Duborgel S, Collignon A, Le Guern ME, Bernasconi P, Petit JC.

Arch Intern Med. 1996 Jul 8;156(13):1449-54.

PMID:
8678714
20.

Prevalence of and risk factors for Clostridium difficile colonization at admission to an infectious diseases ward.

Hutin Y, Casin I, Lesprit P, Welker Y, Decazes JM, Lagrange P, Modaï J, Molina JM.

Clin Infect Dis. 1997 May;24(5):920-4.

PMID:
9142793

Supplemental Content

Support Center